New Chi Scientific CSD01 Friability Tester
| Brand | New Chi Scientific (Scientz) |
|---|---|
| Origin | Zhejiang, China |
| Manufacturer Type | Direct Manufacturer |
| Country of Origin | China |
| Model | CSD01 |
| Pricing | Available Upon Request |
Overview
The New Chi Scientific CSD01 Friability Tester is a precision-engineered laboratory instrument designed to quantitatively assess the mechanical robustness of uncoated and film-coated tablets under controlled rotational stress. It operates in strict accordance with the friability test methodology outlined in the Chinese Pharmacopoeia (ChP) Volume IV, General Chapter 0921, and aligns with internationally recognized principles described in USP <1216>, EP 2.9.7, and JP 6.05. The device subjects tablet samples to repeated tumbling within a standardized rotating drum—simulating mechanical stresses encountered during manufacturing, packaging, transportation, and handling. By measuring mass loss after a defined number of revolutions, the CSD01 delivers objective, reproducible data critical for quality control (QC) release testing and formulation development.
Key Features
- Compliant drum geometry: Internal drum diameter 286 mm ± 2 mm, depth 39 mm ± 1 mm, with an internal radial baffle extending from center to wall (baffle inner diameter 80 mm ± 1 mm), ensuring consistent tablet trajectory and impact dynamics per ChP specifications.
- Precise rotational control: Motor-driven drum rotation at 25 ± 1 rpm, maintained via closed-loop speed regulation for high inter-run repeatability.
- Optically transparent drum housing: Constructed from abrasion-resistant polymer (e.g., polycarbonate or modified acrylic), enabling real-time visual monitoring without interrupting operation.
- Dual-mode operation: Supports both standard 100-revolution tests (4 minutes @ 25 rpm) and user-defined cycle durations for method development or non-standard protocols.
- Stable mechanical architecture: Heavy-duty base, vibration-dampened mounting, and balanced drum assembly minimize external interference and ensure long-term calibration stability.
- Integrated safety interlock: Drum access door automatically halts rotation when opened, complying with IEC 61000-6-2/6-4 electromagnetic compatibility and basic functional safety expectations for lab instrumentation.
Sample Compatibility & Compliance
The CSD01 accommodates standard tablet batches weighing 6.5 g ± 0.1 g (typically 20–30 tablets, depending on average unit mass), as required by ChP and USP. It is validated for use with immediate-release, sustained-release, enteric-coated, and sugar-coated solid oral dosage forms. All materials in contact with samples—including drum interior, baffle surface, and lid seal—are chemically inert, non-reactive, and compliant with ISO 10993-5 (cytotoxicity) and USP <661.1> (plastic materials). Instrument qualification documentation supports IQ/OQ execution per GMP Annex 15 and FDA guidance on analytical instrument qualification (AIQ). Data integrity is maintained through operator-accessible audit trail logs (where integrated with optional PC interface), supporting compliance with 21 CFR Part 11 when paired with validated software environments.
Software & Data Management
The CSD01 operates as a standalone hardware platform with front-panel digital display (rpm, elapsed time, cycle count). While it does not include embedded data storage or network connectivity, its analog/digital I/O interface allows integration with external laboratory information management systems (LIMS) or electronic lab notebooks (ELN) via RS-232 or USB-to-serial adapters. Optional companion software—available separately from New Chi Scientific—enables automated test logging, pass/fail threshold configuration (e.g., ≤1.0% mass loss), statistical summary generation (mean, SD, RSD), and PDF report export conforming to ALCOA+ principles. All software modules undergo periodic verification per GxP requirements, including version control, change management, and backup validation.
Applications
- Batch release testing of tablet formulations prior to distribution.
- Comparative evaluation of coating integrity across different film polymer types (e.g., HPMC vs. ethylcellulose).
- Stability-indicating method development for accelerated aging studies (e.g., assessing friability changes after 40°C/75% RH exposure).
- Process parameter optimization in rotary tablet presses and fluid-bed coaters.
- Regulatory submission support: Raw data and metadata generated meet ICH M4Q(R2) documentation standards for pharmaceutical dossiers.
- Educational use in pharmacy and pharmaceutics curricula for hands-on understanding of solid dosage form mechanics.
FAQ
What pharmacopoeial standards does the CSD01 comply with?
The CSD01 is engineered to meet the physical dimensions, rotational speed, and operational parameters specified in the Chinese Pharmacopoeia (ChP) 2020 Edition, Chapter 0921. Its design also satisfies the functional equivalence criteria of USP <1216>, Ph. Eur. 2.9.7, and JP 6.05.
Is calibration certification included with the instrument?
A factory calibration report verifying rotational speed accuracy (±1 rpm tolerance) and dimensional conformity (drum ID/depth/baffle ID) is supplied with each unit. On-site calibration services and annual requalification support are available through New Chi Scientific’s authorized service network.
Can the CSD01 be used for capsules or softgels?
No. The CSD01 is specifically validated for rigid solid oral dosage forms—primarily tablets—as defined in regulatory monographs. Capsules and softgels require alternative mechanical stress assessment methods (e.g., capsule friability testers per USP <1217>).
What maintenance is required for long-term reliability?
Routine maintenance includes weekly cleaning of the drum interior with lint-free isopropyl alcohol wipes, monthly inspection of drive belt tension and baffle fasteners, and annual motor brush inspection (for brushed DC motor variants). Lubrication is not required—bearing assemblies are sealed and lifetime greased.
Does the instrument support GLP-compliant data archiving?
In standalone mode, manual transcription of results is required. When integrated with validated third-party LIMS or New Chi’s optional software suite (v3.2+), full electronic records—including timestamps, operator IDs, and instrument state logs—are generated and archived in accordance with OECD GLP Principles and FDA 21 CFR Part 11 Subpart B requirements.
